Clinical efficacy of different doses of folic acid combined with vitamin B12 in the treatment of senile hypertension with hyperhomocysteinemia
返回论文页
|更新时间:2021-08-23
|
Clinical efficacy of different doses of folic acid combined with vitamin B12 in the treatment of senile hypertension with hyperhomocysteinemia
Health Medicine Research and PracticeVol. 16, Issue 3, Pages: 5-9(2019)
作者机构:
中国人民解放军陆军第九五八医院干部病房
作者简介:
基金信息:
DOI:
CLC:R589;R544.1
Published:2019,
扫 描 看 全 文
Mao Mei, Wang Li, Qin Lei, et al. Clinical efficacy of different doses of folic acid combined with vitamin B12 in the treatment of senile hypertension with hyperhomocysteinemia. [J]. Health Medicine Research and Practice 16(3):5-9(2019)
DOI:
Mao Mei, Wang Li, Qin Lei, et al. Clinical efficacy of different doses of folic acid combined with vitamin B12 in the treatment of senile hypertension with hyperhomocysteinemia. [J]. Health Medicine Research and Practice 16(3):5-9(2019)DOI:
Clinical efficacy of different doses of folic acid combined with vitamin B12 in the treatment of senile hypertension with hyperhomocysteinemia
Objective To assess the effects of different doses of folic acid combined with vitamin B
12
on the homocysteine(Hcy)
folic acid
and blood pressure levels in elderly hypertensive patients complicated with hyperhomocysteinemia(also referred to as"H-type hypertension").Methods A total of 140 patients with H-type hypertension who underwent health check-up in Xipeng Town
Jiulongpo District
Chongqing between January and May
2015 were included in this study.These patients were divided into the control group(routine anti-hypertensive treatment
n=36)
folic acid group A(routine treatment+folic acid 0.4 mg+vitamin B
12
500μg
n=60)
and folic acid group B(routine treatment+folic acid 0.8 mg+vitamin B
12
500μg
n=44).Results At week 12
the Hcy levels in the control group
folic acid group A
and folic acid group B were 26.73±8.99μmol/L
16.26±5.71μmol/L
and 16.59±6.12μmol/L
respectively;and the differences were statistically significant among the three groups(P
<
0.05).The Hcy levels were significantly reduced from baseline in both group A and group B(P
<
0.05)
also significantly lower than that in the control group(P
<
0.05).At week 12
the folic acid levels in the control group
folic acid group A
and folic acid group B were 3.88±1.37μg/L
10.72±3.39μg/L
and 12.78±4.73μg/L
respectively;and the differences were statistically significant among the three groups(P
<
0.05).The folic acid levels were significantly increased from baseline in both group A and group B(P
<
0.05)
also significantly higher than that in the control group(P
<
0.05).The folic acid level in group B was significantly higher than that in group A(P
<
0.05).Also at week 12
the systolic blood pressure(SBP)levels in the control group
folic acid group A
and folic acid group B were 141.2±10.9 mmHg(1 mmHg=0.133 kPa)
133.8±10.6 mmHg
and 129.3±7.8 mmHg
respectively;and the differences were statistically significant among the three groups(P
<
0.05).The SBP levels in both group A and group B were significantly lower than that in the control group(P
<
0.05).Of note
no adverse reactions such as drug allergy
hepatic or renal toxicities were reported in any group during the study.Conclusion Proper doses of folic acid and vitamin B
12
may significantly reduce the Hcy level
increase the folic acid level
and improve the blood pressure.Besides
folic acid 0.8 mg daily seems to be superior to 0.4 mg daily in reducing the Hcy and SBP levels
which deserves widespread application in primary healthcare settings.